Published in J Biol Chem on December 31, 1999
Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev (2004) 5.80
The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J (2000) 2.08
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci U S A (2004) 1.77
Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev (2010) 1.73
High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-anchored protein and is not blocked by inhibition of the clathrin-mediated pathway of endocytosis. Mol Biol Cell (2000) 1.51
A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J Bacteriol (2001) 1.47
Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain. Proc Natl Acad Sci U S A (2007) 1.46
Helicobacter pylori counteracts the apoptotic action of its VacA toxin by injecting the CagA protein into gastric epithelial cells. PLoS Pathog (2009) 1.40
Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin. Infect Immun (2001) 1.19
Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front Cell Infect Microbiol (2012) 1.17
Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol (2009) 1.13
Characterization of dominantly negative mutant ClyA cytotoxin proteins in Escherichia coli. J Bacteriol (2003) 1.10
Helicobacter pylori vacuolating cytotoxin A (VacA) engages the mitochondrial fission machinery to induce host cell death. Proc Natl Acad Sci U S A (2011) 1.08
Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Infect Immun (2011) 1.05
Clustering and redistribution of late endocytic compartments in response to Helicobacter pylori vacuolating toxin. Mol Biol Cell (2004) 1.04
Mutational analysis of the Helicobacter pylori vacuolating toxin amino terminus: identification of amino acids essential for cellular vacuolation. Infect Immun (2000) 1.01
A Tale of Two Toxins: Helicobacter Pylori CagA and VacA Modulate Host Pathways that Impact Disease. Front Microbiol (2010) 1.00
Dominant-negative inhibitors of the Clostridium perfringens epsilon-toxin. J Biol Chem (2009) 0.99
Amino-terminal hydrophobic region of Helicobacter pylori vacuolating cytotoxin (VacA) mediates transmembrane protein dimerization. Infect Immun (2001) 0.99
Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10. Proc Natl Acad Sci U S A (2014) 0.97
Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA). Front Cell Infect Microbiol (2012) 0.96
Helicobacter pylori VacA toxin/subunit p34: targeting of an anion channel to the inner mitochondrial membrane. PLoS Pathog (2010) 0.95
Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolating cytotoxin within mammalian cells. Infect Immun (2002) 0.92
Helicobacter pylori VacA subdomain required for intracellular toxin activity and assembly of functional oligomeric complexes. Infect Immun (2008) 0.92
Helicobacter pylori vacuolating toxin A and apoptosis. Cell Commun Signal (2011) 0.92
Dominant negative mutants of Bacillus thuringiensis Cry1Ab toxin function as anti-toxins: demonstration of the role of oligomerization in toxicity. PLoS One (2009) 0.91
Resistance of primary murine CD4+ T cells to Helicobacter pylori vacuolating cytotoxin. Infect Immun (2006) 0.91
Molecular cross-talk between Helicobacter pylori and human gastric mucosa. World J Gastroenterol (2011) 0.90
Antigenic diversity among Helicobacter pylori vacuolating toxins. Infect Immun (2001) 0.88
Expression of Helicobacter pylori vacuolating toxin in Escherichia coli. Infect Immun (2003) 0.87
Reconstitution of Helicobacter pylori VacA toxin from purified components. Biochemistry (2010) 0.87
A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype. Infect Immun (2006) 0.87
Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin. Infect Immun (2003) 0.86
The intermediate region of Helicobacter pylori VacA is a determinant of toxin potency in a Jurkat T cell assay. Infect Immun (2012) 0.86
the versatility of the Helicobacter pylori vacuolating cytotoxin vacA in signal transduction and molecular crosstalk. Toxins (Basel) (2010) 0.86
Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis. EMBO Rep (2016) 0.86
Helicobacter pylori VacA toxin inhibits human immunodeficiency virus infection of primary human T cells. J Virol (2006) 0.83
Targeting of Helicobacter pylori VacA to mitochondria. Gut Microbes (2011) 0.83
Structural analysis of the oligomeric states of Helicobacter pylori VacA toxin. J Mol Biol (2012) 0.82
An Overview of Helicobacter pylori VacA Toxin Biology. Toxins (Basel) (2016) 0.81
Dominant negative phenotype of Bacillus thuringiensis Cry1Ab, Cry11Aa and Cry4Ba mutants suggest hetero-oligomer formation among different Cry toxins. PLoS One (2011) 0.81
Random mutagenesis of Helicobacter pylori vacA to identify amino acids essential for vacuolating cytotoxic activity. Infect Immun (2006) 0.81
Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein. Infect Immun (2006) 0.81
Analysis of a beta-helical region in the p55 domain of Helicobacter pylori vacuolating toxin. BMC Microbiol (2010) 0.81
Mimicry of a host anion channel by a Helicobacter pylori pore-forming toxin. Biophys J (2005) 0.80
How the loop and middle regions influence the properties of Helicobacter pylori VacA channels. Biophys J (2001) 0.79
Structural organization of membrane-inserted hexamers formed by Helicobacter pylori VacA toxin. Mol Microbiol (2016) 0.76
A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain. Infect Immun (2016) 0.76
VacA's Induction of VacA-Containing Vacuoles (VCVs) and Their Immunomodulatory Activities on Human T Cells. Toxins (Basel) (2016) 0.75
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res (1995) 11.07
Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun (1993) 7.75
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Divalent ions and the surface potential of charged phospholipid membranes. J Gen Physiol (1971) 6.04
Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology (1997) 5.24
Reconstitution of a functional core polycomb repressive complex. Mol Cell (2001) 4.39
A Drosophila Polycomb group complex includes Zeste and dTAFII proteins. Nature (2001) 3.90
Analysis of flanking sequences from dissociation insertion lines: a database for reverse genetics in Arabidopsis. Plant Cell (1999) 3.65
Surface charge and the conductance of phospholipid membranes. Proc Natl Acad Sci U S A (1970) 3.54
Molecular evolution by staggered extension process (StEP) in vitro recombination. Nat Biotechnol (1998) 3.52
Uncoupling of cardiac muscarinic and beta-adrenergic receptors from ion channels by a guanine nucleotide analogue. Nature (1985) 3.44
Centre-surround inhibition among olfactory bulb glomeruli. Nature (2003) 3.31
The SPOROCYTELESS gene of Arabidopsis is required for initiation of sporogenesis and encodes a novel nuclear protein. Genes Dev (1999) 3.07
Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology (1995) 2.99
Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus. Mol Microbiol (1995) 2.96
Helicobacter pylori and gastric acid: biological and therapeutic implications. Gastroenterology (1996) 2.96
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene (2012) 2.82
Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants. Mol Microbiol (1991) 2.47
Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem (1998) 2.44
Brain MR in Fukuyama congenital muscular dystrophy. AJNR Am J Neuroradiol (1996) 2.42
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene (2012) 2.41
Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun (1994) 2.37
Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem (1998) 2.37
Quantitative analysis of neuronal diversity in the mouse olfactory bulb. J Comp Neurol (2007) 2.27
Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J Infect Dis (1996) 2.24
Absorption, tissue concentration, and organ distribution of cefazolin. Antimicrob Agents Chemother (Bethesda) (1970) 2.13
Freezing and melting of lipid bilayers and the mode of action of nonactin, valinomycin, and gramicidin. Science (1971) 2.13
Fukuyama-type congenital muscular dystrophy and the Walker-Warburg syndrome. Brain Dev (1993) 2.08
Binding and internalization of the Helicobacter pylori vacuolating cytotoxin by epithelial cells. Infect Immun (1996) 2.08
Characteristics of Helicobacter pylori variants selected for urease deficiency. Infect Immun (1992) 2.01
Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun (1993) 1.97
The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc Natl Acad Sci U S A (1998) 1.95
Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J Bacteriol (2000) 1.94
Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun (1995) 1.93
Gramicidin forms multi-state rectifying channels. Nature (1981) 1.93
Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol (1997) 1.90
Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. Hum Pathol (2001) 1.87
Detection of Helicobacter pylori gene expression in human gastric mucosa. J Clin Microbiol (1995) 1.86
Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res (1999) 1.81
Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12. J Bacteriol (1993) 1.78
The effect of spinning conditions on the mechanics of a spider's dragline silk. Proc Biol Sci (2001) 1.78
Ionic probes of membrane structures. Ann N Y Acad Sci (1972) 1.74
Sympathetic regulation of cardiac calcium current is due exclusively to cAMP-dependent phosphorylation. Nature (1991) 1.73
A dimer as a building block in assembling RNA. A hexamer that gears bacterial virus phi29 DNA-translocating machinery. J Biol Chem (2000) 1.73
Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol (1999) 1.69
Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest (1992) 1.66
Mechanism of muscarinic receptor-induced K+ channel activation as revealed by hydrolysis-resistant GTP analogues. J Gen Physiol (1988) 1.64
Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol (2001) 1.63
Dual mechanism for the action of cholesterol on membrane permeability. Nature (1974) 1.62
Type 1 fimbriation and fimE mutants of Escherichia coli K-12. J Bacteriol (1991) 1.61
The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc Natl Acad Sci U S A (1999) 1.61
Some theoretically expected and experimentally observed properties of lipid bilayer membranes containing neutral molecular carriers of ions. Fed Proc (1969) 1.56
Refolded outer membrane protein A of Escherichia coli forms ion channels with two conductance states in planar lipid bilayers. J Biol Chem (2000) 1.55
New approach for atomic force microscopy of membrane proteins. The imaging of cholera toxin. J Mol Biol (1993) 1.54
Intercellular communication in Helicobacter pylori: luxS is essential for the production of an extracellular signaling molecule. Infect Immun (2000) 1.53
Molecular resolution atomic force microscopy of soluble proteins in solution. Biochim Biophys Acta (1994) 1.53
p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes. Gynecol Oncol (1996) 1.51
Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect Immun (1996) 1.51
A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J Bacteriol (2001) 1.47
Vascular tracheobronchial compression syndromes-- experience in surgical treatment and literature review. Thorac Cardiovasc Surg (2000) 1.47
Quality of life in patients with small abdominal aortic aneurysm: the effect of early endovascular repair versus surveillance in the CAESAR trial. Eur J Vasc Endovasc Surg (2010) 1.46
The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J Biol Chem (1995) 1.46
High-resolution atomic-force microscopy of DNA: the pitch of the double helix. FEBS Lett (1995) 1.46
Three cases of malignant hypertension: the roles of endothelin-1 and the renin-angiotensin-aldosterone system. Clin Nephrol (1994) 1.44
The possible subduction of continental material to depths greater than 200 km. Nature (2000) 1.44
Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J Pediatr (1999) 1.44
Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases. J Infect Dis (1992) 1.44
Unitary anion currents through phospholemman channel molecules. Nature (1995) 1.43
Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology (1999) 1.43
Identification of the minimal intracellular vacuolating domain of the Helicobacter pylori vacuolating toxin. J Biol Chem (1999) 1.43
Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci (1987) 1.42
beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci (2001) 1.42
Retracted Role of opioid delta1 receptors, mitochondrial K(ATP) channels, and protein kinase C during cardiocyte apoptosis. J Mol Cell Cardiol (2001) 1.41
Cryo atomic force microscopy: a new approach for biological imaging at high resolution. Biochemistry (1995) 1.40
No benefit from carotid intervention in fatal stroke prevention for >80-year-old patients. Eur J Vasc Endovasc Surg (2012) 1.39
Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke (2000) 1.39
Staphylococcal alpha-hemolysin can form hexamers in phospholipid bilayers. J Mol Biol (1998) 1.38
Tris(hydroxymethyl)aminomethane (C4H11NO3) induced a ripple phase in supported unilamellar phospholipid bilayers. Biochemistry (1994) 1.37
Planar bilayer membranes from pure lipids. Biochim Biophys Acta (1979) 1.36
Reperfusion injury on cardiac myocytes after simulated ischemia. Am J Physiol (1996) 1.35
Atomic force microscopy of cholera toxin B-oligomers bound to bilayers of biologically relevant lipids. J Mol Biol (1995) 1.34
Analysis of genetic diversity in cytotoxin-producing and non-cytotoxin-producing Helicobacter pylori strains. J Infect Dis (1995) 1.34
Large divalent cations and electrostatic potentials adjacent to membranes. Experimental results with hexamethonium. Biophys J (1983) 1.34
Atomic force microscopy of DNA molecules. FEBS Lett (1992) 1.34
Two GABAergic intraglomerular circuits differentially regulate tonic and phasic presynaptic inhibition of olfactory nerve terminals. J Neurophysiol (2009) 1.32
Effect of probe force on the resolution of atomic force microscopy of DNA. Ultramicroscopy (1993) 1.31
Comparison of MADS box gene expression in developing male and female flowers of the dioecious plant white campion. Plant Cell (1994) 1.31
Proton transfer from Asp-96 to the bacteriorhodopsin Schiff base is caused by a decrease of the pKa of Asp-96 which follows a protein backbone conformational change. Biochemistry (1993) 1.30
VacA from Helicobacter pylori: a hexameric chloride channel. FEBS Lett (1999) 1.29